HomeCompareFGHQF vs PLD

FGHQF vs PLD: Dividend Comparison 2026

FGHQF yields 1333.33% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FGHQF wins by $241528694.70M in total portfolio value
10 years
FGHQF
FGHQF
● Live price
1333.33%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$241528700.61M
Annual income
$210,475,860,072,406.56
Full FGHQF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — FGHQF vs PLD

📍 FGHQF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFGHQFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FGHQF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FGHQF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FGHQF
Annual income on $10K today (after 15% tax)
$113,333.33/yr
After 10yr DRIP, annual income (after tax)
$178,904,481,061,545.56/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, FGHQF beats the other by $178,904,477,023,429.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FGHQF + PLD for your $10,000?

FGHQF: 50%PLD: 50%
100% PLD50/50100% FGHQF
Portfolio after 10yr
$120764353.26M
Annual income
$105,237,932,411,565.88/yr
Blended yield
87.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

FGHQF
No analyst data
Altman Z
2.4
Piotroski
6/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FGHQF buys
0
PLD buys
0
No recent congressional trades found for FGHQF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFGHQFPLD
Forward yield1333.33%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$241528700.61M$5.91M
Annual income after 10y$210,475,860,072,406.56$4,750,725.19
Total dividends collected$239239876.27M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: FGHQF vs PLD ($10,000, DRIP)

YearFGHQF PortfolioFGHQF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$144,033$133,333.33$11,241$540.96+$132.8KFGHQF
2$1,948,924$1,794,807.89$13,019$991.13+$1.94MFGHQF
3$24,782,219$22,696,870.86$15,801$1,870.97+$24.77MFGHQF
4$296,245,945$269,728,970.81$20,609$3,701.21+$296.23MFGHQF
5$3,330,378,004$3,013,394,842.54$29,919$7,867.97+$3330.35MFGHQF
6$35,223,684,321$31,660,179,856.69$50,631$18,617.74+$35223.63MFGHQF
7$350,636,384,108$312,947,041,885.16$105,528$51,352.20+$350636.28MFGHQF
8$3,286,630,500,315$2,911,449,569,318.85$287,364$174,449.42+$3286630.21MFGHQF
9$29,021,346,295,663$25,504,651,660,325.88$1,081,760$774,280.77+$29021345.21MFGHQF
10$241,528,700,608,766$210,475,860,072,406.56$5,908,209$4,750,725.19+$241528694.70MFGHQF

FGHQF vs PLD: Complete Analysis 2026

FGHQFStock

Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services that include study designs, execution of studies, and interpretation of the data through structural optimization in early discovery, pharmacokinetic studies in rodents, non- GLP bioanalytical studies, etc. The company also provides safety and toxicology services comprising in-vitro and in-vivo studies; bioequivalence services, which consist of designing, coordinating, and reporting of bioequivalence studies; chemistry services comprising contract research and custom synthesis services; and clinical services, such as early stage clinical, BE/BA, biometric, and data management services. It operates in the United States, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation is a subsidiary of Hongkong Tigermed Co., Limited.

Full FGHQF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this FGHQF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FGHQF vs SCHDFGHQF vs JEPIFGHQF vs OFGHQF vs KOFGHQF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.